Factors associated with treatment outcomes in an aftercare population

American Journal on Addictions

Volumn 13, Issue 5, 2004, Pages 447-460

  Brown, Barry S ^a,c   O'Grady, Kevin ^b,c   Battjes, Robert J ^c   Farrell, Eugene V ^c  

^a UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Friends Social Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFTERCARE; ALCOHOL ABUSE; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OFFENDER; OPIATE ADDICTION; PREDICTION; RATING SCALE; SOCIAL BEHAVIOR; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AFTERCARE; COUNSELING; FEMALE; HUMANS; MALE; MENTAL HEALTH; OUTPATIENTS; PRISONERS; PUBLIC POLICY; REGRESSION ANALYSIS; RESIDENCE CHARACTERISTICS; SPIRITUALITY; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 10044280418     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1080/10550490490512780     Document Type: Article

References (63)

1. Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC: University of North Carolina Press; 1989.
2. Simpson DD, Brown BS eds. Treatment process and outcome studies from DATOS. Drug Alcohol Depend. 1999;57(2).
3. Simpson DD, Sells SB. Opioid Addiction and Treatment: A Twelve Year Follow-up. Malabar, Fla.: Robert E. Krieger Publishing Co. 1990.
4. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of one-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Disorders. 1997;11:261-278.
5. Simpson DD, Joe GW, Broome KM, Miller MS, Knight K, Rowan-Szal GA. Program diversity and treatment retention rates in the drug abuse treatment outcomes study (DATOS). Psychol Addict Behav. 1997;11:279-293.
6. Simpson DD, Joe GW, Brown BS. Treatment retention and follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav. 1997;11:297-307.
7. Joe GW, Simpson DD, Broome KM, Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend. 1999;57:113-125.
8. Simpson DD, Modeling treatment process and outcomes. Addiction. 2001;96:207-211.
9. Brewer DD, Catalano RF, Haggerty K, Gainey RR, Fleming CB. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction. 1998;93:73-92.
10. Anglin MD, Hser Y-I. Treatment of drug abuse. In: Tonry M, Wilson JQ, eds, Drugs and Crime. Chicago, III.: University of Chicago Press; 1990;393-458.
11. Broome KM, Flynn PM, Simpson DD. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Serv Res. 1999;34:791-806.
12. McLellan AT. Psychiatric severity as a predictor of outcome from substance abuse treatments. In: Meyer RE, ed. Psychopathology and Addicitive Disorders. New York, NY: Guilford; 1986;85-93.
13. McLellan AT, Alterman AL, Metzger DS, et al. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services. J Consult Clin Psychol. 1994;62:1141-1158.
14. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to drug and alcohol treatments: role of psychiatric severity. Arch Gen Psychiatry. 1983;40:620-625.
15. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychiatric disorders in treated opiate addicts. Arch Gen Psychiatry. 1986;43:739-745.
16. Rounsaville BJ, Tierney T, Crits-Chrisotoph K, Weissman MM, Kleber HD. Predictors of outcome in treatment of opiate addicts: evidence for the multidimensional nature of addicts' problems. Compre Psychiatry. 1982;23:462-478.
17. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Severity of psychiatric symptoms as a predictor of benefits of psychotherapy: the VA- Penn study. Am J Psychiatry. 1984;141:1172-1177.
18. Agosti V, Nunes E, Stewart JW, Quitken FM. Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report. Int J Addict. 1991;26:327-334.
19. Joe GW, Brown BS, Simpson DD. Psychological problems and client engagement in methadone vestment. J Nerv Ment Dis. 1995;183:704-710.
20. Hser Y-I, Grella CE, Chou CP, Anglin MD. Relationships between drug treatment careers and outcomes: findings from the National Drug Abuse Treatment Outcome Study. Eval Rev. 1998;22:496-519.
21. Hser Y-I, Grella CE, Hsieh S-C, Anglin MD, Brown BS. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 1999;57:137-150.
22. Powers KI, Anglin MD. Cumulative versus stabilizing effects of methadone maintenance: a quasi-experimental study using longitudinal self-report data. Eval Rev. 1993;17:243-270.
23. Condelli WS, De Leon G. Fixed and dynamic predictors of client outcomes in therapeutic communities. J Subst Abuse Treat. 1993;10:11-16.
24. Condelli WS, Hubbard RL. Relationship between time spent in treatment and client outcomes from therapeutic communities. J Subst Abuse Treat. 1994;11:25-33.
25. Simpson DD. The relationship of time spent in drug abuse treatment to post-treatment outcomes. Am J Psychiatry. 1979;136:1449-1453.
26. Simpson DD. Treatment for drug use: follow-up outcomes and length of time in treatment. Arch Gen Psychiatry. 1981;38:875-880.
27. Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag; 1991.
28. Hoffman JA, Caudill BD, Koman JJ, Luckey JW, Flynn PM, Hubbard RL. Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure. J Addict Dis. 1994;13:115-128.
29. Joe GW, Simpson DD, Sells SB. Treatment process and relapse to opioid use during methadone maintenance. Am J Drug Alcohol Abuse. 1992;19:124-130.
30. McLellan AT, Arndt IO, Woody GE, Metzger D. Psychosocial services in substance abuse services? A dose-ranging study of psychosocial services. JAMA. 1993;269:1953-1959.
31. McLellan AT, Grissom GR, Brill P, Durell J, Metzger DS, O'Brien CP. Private substance abuse treatments: are some programs more effective than others? J Subst Abuse Treat. 1993;10:243-254.
32. Shoptaw S, Rawson RA, McCann MJ, Obert JL. The Matrix Model of outpatient stimulant abuse treatment: evidence of efficacy. J Addict Dis. 1994;13:129-141.
33. Brown BS, O'Grady KE, Battjes RJ, Farrell EV, Smith NP, Nurco DN. Effectiveness of a standalone aftercare program for drug-involved offenders. J Subst Abuse Treat. 2001;1:185-192.
34. Hawkins JD, Catalano RF. Aftercare in drug abuse treatment. Int J Addict. 1985;20:917-945.
35. Inciardi JA. HIV risk reduction and service delivery strategies in criminal justice settings. J Subst Abuse Treat. 1996;13:421-428.
36. Inciardi JA, Marin SS, Butzin CA, Hooper RM, Harrison LD. An effective model of prison-based treatment for drug-involved offenders, J Drug Issues. 1997;27:261-278.
37. Knight K, Simpson DD, Hiller ML. Three-year reincarceration outcomes for therapeutic community treatment in Texas. Prison Journal. 1999;79:337-351.
38. Martin SS, Butzin CA, Saum CE, Inciardi JA. Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: from prison to work release to aftercare. Prison Journal. 1999;79:294-320.
39. McAuliffe WE, Chien JMN. Recovery training and self-help: a relapse prevention program for treated heroin addicts. J Subst Abuse Treat. 1986;3:9-20.
40. Wexler HK, Melnick G, Lowe L, Peters J. Three-year reincarceration outcomes for Amity in-prison therapeutic community and aftercare in California. Prison Journal. 1999;79:321-336.
41. Goehl L, Nunes E, Quitkin F, Hilton I. Social networks and methadone treatment outcome: the costs and benefits of social ties. Am J Drug Alcohol Abuse. 1993;19:251-262.
42. Havassy BE, Hall SM, Wasserman DA. Social support and relapse: commonalities among alcoholics, opiate users, and cigarette smokers. Addict Behav. 1991;16:235-246.
43. Havassy BE, Hall SM, Wasserman DA. Social relationships and abstinence from cocaine in an American treatment sample. Addiction. 1995;90:699-710.
44. Hawkins JD, Fraser MW. The social networks of drug uses before and after treatment. Int J Addict. 1987;22:343-353.
45. Waldorf D. Natural recovery from opiate addiction: some social-psychological processes of untreated recovery. J Drug Issues. 1983;13:237-280.
46. Broome KM, Simpson DD, Joe GW. The role of social support following short-term inpatient treatment. Am J Addict. 2002;11:57-65.
47. Hser Y-I, Grella CE, Hsieh SC, Anglin MD, Brown BS. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 1999;57:137-150.
48. Hanlon TE, Nurco DN, Bateman RW, O'Grady KR. The response of drug abuser parolees to a combination of treatment and intensive supervision. Prison Journal. 1998;78:31-34.
49. Gogineni A, Stein MD, Friedmann PD. Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend. 2001;64:47-53.
50. Pivnick A, Jacobsen A, Eric K, Doll L, Drucker E. AIDS, HIV infections and illicit drug use within inner-city families and social networks. Am J Public Health. 1994;84:271-274.
51. Corrington JE. Spirituality and recovery: relationship between levels of spirituality, contentment, and stress during recovery from alcoholism in A.A. Alcoholism Treatment Quarterly. 1989;64:151-160.
52. Nealon-Woods MA, Ferrari JR, Jason LA. Twelve-step program use among Oxford House residents: spirituality or social support in sobriety? J Subst Abuse. 1995;7:311-318.
53. Peteet JR. A closer look at the role of a spiritual approach in addictions treatment. J Subst Abuse Treat. 1993;10:263-267.
54. Warfield RD, Goldstein MB. Spirituality: the key to recovery from alcoholism. Counseling and Values. 1996;40:196-205.
55. Pardini DA, Plante TG, Sherman A, Stump JE. Religious faith and spirituality in substance abuse recovery: determining the mental health benefits. J Subst Abuse Treat. 2000;19:347-354.
56. Simpson DD, Chatham LR. TCU/DATAR Forms Manual. Fort Worth, Tex.: Institute of Behavioral Health; 1995.
57. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976;128:280-289.
58. Beck AT, Steer RA. Manual for the Beck Hopelessness Scale. San Antonio, Tex.: Psychological Corporation; 1988.
59. Hawkins JD, Catalano RF. Aftercare in drug abuse treatment. Int J Addict. 1985;20:917-945.
60. Simpson DD, Wexler HK, Inciardi JA, eds. Drug treatment outcomes for correctional settings, Part One. [Special Issue]. Prison Journal. 1999;79:291-368.
61. McLellan AT. Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction. 2002;97:249-252.
62. McLellan AT, O'Brien CP, Lewis D, Kleber HD. Drug addiction as a chronic medical illness: implications for treatment, insurance, and evaluation JAMA. 2000;284:1689-1695.
63. Crape BL, Latkin CA, Laris AS, Knowlton AR. The effects of sponsorship in twelve-step treatment of injection drug users. Drug Alcohol Depend. 2002;65:291-301.